IART(Integra LifeSciences Holdings Corporation) · 财务报表

IART(Integra LifeSciences Holdings Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$1.54B$1.56B$1.54B$1.61B$1.64B
毛利润$944.64M$970.31M$884.74M$882.06M$831.62M
营业利润$197.23M$238.92M$111.53M$28.41M−$493.37M
净利润$169.07M$180.55M$67.74M−$6.94M−$516.47M
经营现金流$312.43M$264.47M$139.96M$129.38M$50.38M
自由现金流$264.40M$222.13M$73.09M$24.96M−$31.05M
摊薄每股收益$1.98$2.16$0.84$-0.09$-6.74

Integra LifeSciences Holdings Corporation IART